A Study of SY-1365 in Adult Patients With Advanced Solid Tumors
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Advanced Solid Tumors|Ovarian Cancer|Breast Cancer
Interventions: DRUG: SY-1365 (Part 1)|DRUG: Carboplatin|DRUG: Fulvestrant|DRUG: SY-1365 (Cohort 2)|DRUG: SY-1365 (Cohort 5)|DRUG: SY-1365 (Part 2 Single Agent)
Sponsor: Syros Pharmaceuticals